Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial

PURPOSE: SORAMIC is a randomized controlled trial in patients with advanced hepatocellular carcinoma (HCC) undergoing sorafenib ± selective internal radiation therapy (SIRT). We investigated the value of extracellular vesicle (EV)-based proteomics for treatment response prediction. EXPERIMENTAL DESI...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuen, Timothy Wai Ho, Alunni-Fabbroni, Marianna, Öcal, Elif, Malfertheiner, Peter, Wildgruber, Moritz, Schinner, Regina, Pech, Maciej, Benckert, Julia, Sangro, Bruno, Kuhl, Christiane, Gasbarrini, Antonio, Chow, Pierce Kah Hoe, Toh, Han Chong, Ricke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433961/
https://www.ncbi.nlm.nih.gov/pubmed/35763041
http://dx.doi.org/10.1158/1078-0432.CCR-22-0569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433961/
https://www.ncbi.nlm.nih.gov/pubmed/35763041
http://dx.doi.org/10.1158/1078-0432.CCR-22-0569

Ejemplares similares